ERBB2 and non-small cell lung carcinoma: Discovery ofSTX-721, a Covalent, Potent, and HighlyMutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatmentof Non-Small Cell Lung Cancer